AI tool for breast cancer receives FDA approval, utilizes mammograms to assess risk
The FDA Allows AI Tools to Predict Breast Cancer Risk The U.S. Food and Drug Administration (FDA) has given the green light to an artificial intelligence (AI) tool designed to estimate the risk of breast cancer. This approval is a significant step toward enhancing early detection methods. Clairity, the tech company behind Clarity Breast, has […]
FDA grants limited approval for new Moderna COVID vaccine
Moderna’s New COVID-19 Vaccine Approved by FDA The FDA has given the green light to Moderna’s latest COVID-19 vaccine, known as Mnexspike. This new option is specifically aimed at adults aged 65 and older, along with younger individuals, ages 12 to 64, who have at least one underlying medical condition that puts them at higher […]
FDA notice advises of uncommon but serious itching after stopping allergy medications
Some individuals may face a serious reaction when discontinuing two popular allergy medications. The U.S. Food and Drug Administration (FDA) has issued a warning regarding cetirizine (Zyrtec) and levocetirizine (Xyzal), indicating that those who cease their long-term use could experience “rare but severe itching,” a condition known as Pruritus. This itching has been reported by […]
FDA issues alert about uncommon but serious itching following the use of popular allergy drugs
Hundreds of individuals who have discontinued using allergy medications like Zyrtec and Xyzal have reported experiencing new and uncomfortable side effects, according to a recent warning from the US Food and Drug Administration. The warning highlights that in “rare but severe” instances, those who stop taking these drugs experience intense itching, prompting them to seek […]
FDA intends to restrict who can get the COVID vaccine
Covid Vaccine Approval Limited to High-Risk Groups The Trump administration announced on Tuesday that it intends to restrict access to the updated Covid-19 vaccine primarily to adults aged 65 and older and those considered at high risk for severe illness from the virus. This decision has sparked discussions about what it might mean for healthier […]
FDA plans to withdraw COVID-19 vaccine guidance for children and healthy adults
FDA to Change COVID-19 Vaccine Approval Process The U.S. Food and Drug Administration (FDA) has decided to halt the automatic approval of COVID-19 vaccines for low-risk groups, which includes both children and healthy adults. This shift seems to be aimed at ensuring that only those who are considered healthy by their healthcare providers will automatically […]
FDA revamps COVID vaccine approval process to prioritize older adults and high-risk groups
FDA Updates COVID-19 Vaccine Approval Standards The Food and Drug Administration (FDA) is revising its annual COVID-19 vaccine approval process to hold vaccines for low-risk individuals to a higher standard of evidence. The focus will be on “high-risk” groups, particularly those aged 65 and older. According to Vinay Prasad, the FDA’s head of biological assessment […]
Blood test that aids in diagnosing Alzheimer’s disease gets approval from FDA
Blood Tests for Alzheimer’s Diagnosis Approved In a significant move, U.S. health officials approved the first blood test aimed at diagnosing Alzheimer’s disease, with the hope of identifying potential patients. This test can assist doctors in differentiating whether a patient’s memory issues stem from Alzheimer’s or other medical conditions that affect cognitive function. The FDA […]
First-ever blood test for detecting Alzheimer’s gets FDA approval
FDA Approves First Blood Test for Alzheimer’s Detection The U.S. Food and Drug Administration (FDA) has granted approval for a groundbreaking blood test aimed at detecting Alzheimer’s disease. This new diagnostic device, known as Lumipulse, was announced in a press release on Friday. Designed for adults over 55 who show early signs of Alzheimer’s, this […]
FDA approves first blood test for accurately predicting Alzheimer’s disease
On Friday, the Food and Drug Administration (FDA) revealed a new test designed to diagnose Alzheimer’s disease in adults. This is the first of its kind that uses blood samples to determine the presence of the illness. The test is known as the “Lumipulse g ptau217/ß-amyloid 1-42 plasma ratio” and was developed by Fujirebio Diagnostics, […]